Gene therapy for neuropathic pain using dorsal root ganglion–targeted helper-dependent adenoviral vectors with GAD67 expression

INTRODUCTION: Currently available medications for neuropathic pain are of limited efficacy. Moreover, they are administered systemically and are associated with significant side effects. Ideally, one can circumvent systemic side effects if such treatment can be administered by delivery of the therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Nobuhiro, Terashima, Tomoya, Oka, Kazuhiro, Chan, Lawrence, Kojima, Hideto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344132/
https://www.ncbi.nlm.nih.gov/pubmed/30706038
http://dx.doi.org/10.1097/PR9.0000000000000695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344132/
https://www.ncbi.nlm.nih.gov/pubmed/30706038
http://dx.doi.org/10.1097/PR9.0000000000000695

Ejemplares similares